DVA
DAVITA INC.
NYSE · Healthcare · Medical - Care Facilities · US
$193.31
+5.10%Oct 29, 2026, 22:36 UTC
DAVITA INC. reported quarterly earnings of $3.82 per share, up from $2.51 per share a year earlier and above the Zacks Investment Research, Inc. consensus estimate of $3.78.
Source:Oct 29, 2026, 21:25 UTC
BERKSHIRE HATHAWAY INC sold 382,563 shares of DAVITA INC. at $180.43 per share.
Oct 29, 2026, 20:30 UTC
DAVITA INC. provided fiscal 2026 diluted EPS guidance of $14.30 to $15.20.
Oct 29, 2026, 20:05 UTC
DAVITA INC. reported consolidated revenue of $3.578 billion for the quarter ended September 30, 2026.
Source:Oct 27, 2026, 13:00 UTC
DAVITA INC. reported that nearly 1,000 people received preventive health screenings in Houston and Los Angeles, with a majority showing signs of elevated chronic disease risk.
Source:Oct 23, 2026, 23:01 UTC
DAVITA INC. shares closed at $183.64, down 1.32% from the prior trading day.
Source:Oct 22, 2026, 19:41 UTC
DAVITA INC. shares gained 55.6% year to date.
Source:Oct 20, 2026, 23:59 UTC
The U.S. Department of Health and Human Services introduced its Kidney Care National Plan.
Source:Oct 9, 2026, 23:01 UTC
DAVITA INC. closed at $179.25, up 1.26% from the previous trading session.
Source:Oct 8, 2026, 20:00 UTC
DAVITA INC. activated its emergency response plan as Hurricane Isaias approached the Gulf Coast and southeastern United States, aiming to help patients continue receiving dialysis care and support affected communities.
Source:Sep 24, 2026, 23:00 UTC
DaVita HealthCare (DVA) shares fell 4.62% to settle at $174.67 on the latest trading day.
Source:Sep 21, 2026, 10:01 UTC
DaVita implemented Glean, an enterprise work AI and search platform, to help employees search, retrieve, and summarize medical, insurance, and administrative data.
Source:Sep 2, 2026, 00:00 UTC
DaVita agreed to pay $15 million to settle a proposed class action lawsuit over a data breach that impacted approximately 2.7 million people last year.
Source:Aug 25, 2026, 10:00 UTC
DaVita announced a new value-based care agreement with Humana to deliver coordinated care to Humana Medicare Advantage members with chronic kidney disease stages 3B-5, launched on July 1, 2026.
Source:Aug 25, 2026, 09:17 UTC
BlackRock Inc. purchased 2,460,987 shares of DaVita Inc. during the second quarter, increasing its stake to approximately 3.86% of the company.
Source:Aug 4, 2026, 20:05 UTC
DaVita Inc. announced its financial and operating results for the quarter ended June 30, 2026.
Jul 28, 2026, 11:55 UTC
Xeltis raised €20.5 million in new funding from new and existing shareholders, led by Horizon 3 Healthcare.
Source:Jun 17, 2026, 16:21 UTC
DaVita expands kidney care beyond acute settings through IKC, digital tools and AI.
Source:Jun 8, 2026, 00:00 UTC
DaVita Inc. amended its senior secured credit agreement to add an incremental $500 million tranche of Tranche B-2 Term Loans, with proceeds to repay revolving loans and for general corporate purposes.